Update and new approaches in the treatment of Castleman disease

First described 60 years ago, Castleman disease comprises a rare and heterogeneous cluster of disorders, characterized by lymphadenopathy with unique histological features and associated with cytokine-driven constitutional symptoms and biochemical disturbances. Although unicentric Castleman disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Kah-Lok, Lade, Stephen, Prince, H Miles, Harrison, Simon J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976903/
https://www.ncbi.nlm.nih.gov/pubmed/27536166
http://dx.doi.org/10.2147/JBM.S60514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976903/
https://www.ncbi.nlm.nih.gov/pubmed/27536166
http://dx.doi.org/10.2147/JBM.S60514

Ejemplares similares